Buy Bifidobacterium animalis subsp. lactis F1-7 Probiotics Powder from Trusted China Suppliers and Factory
Deposite: CCTCC M 2020833
Shelf life: 24 months
Storage conditions: Stored at -18℃or lower
Health Benefits
Patents
A strain of Bifidobacterium animalis subsp.lactis F1-7 that promotes intestinal motility and its applications.
Patent Title: A method of preparing a combination of Bifidobacterium animalis subsp.lactis F1-7 and krill oil for ameliorating atherosclerotic inflammation and its application
Literature
1. Reduction of intestinal trimethylamine by probiotics ameliorated lipid metabolic disorders associated with atherosclerosis
2. Study on intestinal survival and cholesterol metabolism of probiotics
3. Evaluation of probiotics for improving and regulation metabolism relevant to type 2 diabetes in vitro
4. Study of gastrointestinal tract viability and motility via modulation of serotonin in a zebrafish model by probiotics
5. Bifidobacterium animalis F1-7 in combination with konjac glucomannan improves constipation in mice via humoral transport
6. Bifidobacterium improves oestrogen-deficiencyinduced osteoporosis in mice by modulating intestinal immunity
7. Krill Oil Combined with Bifidobacterium animalis subsp. lactis F1-7 Alleviates the Atherosclerosis of ApoE Mice
8. Mechanisms underlying the promotion of 5- hydroxytryptamine secretion in enterochromaffin cells of constipation mice by Bifidobacterium and Lactobacillus
9. Probiotics improved hyperlipidemia in mice induced by a high cholesterol diet via downregulating FXR
10. Ameliorative Effect and Mechanism of Probiotics Combined with Resveratrol on Chronic Alcoholic Liver Injury in Mice
Applications
Dairy
Food
Fermented Beverages
Pharmaceuticals
Biotechnology
Feed Additive/Pet
Products List
Products customized are acceptable.
Potency: 10B CFU/g, 50B CFU/g, 100B CFU/g, 200B CFU/g, 300B CFU/g, 400B CFU/g, 500B CFU/g
| Probiotic Strains | Strain number | Potency (BCFU/g) |
|---|---|---|
| Bifidobacterium animalis subsp.lactis | F1-7 | 200 |
| Bifidobacterium animalis subsp.lactis | KV9 | 800 |
| Bifidobacterium animalis subsp.lactis | BA-C9 | 200 |
| Bifidobacterium animalis subsp.lactis | BA-C10 | 800 |
| Bifidobacterium animalis subsp.lactis | BA-C53 | 600 |
| Lactiplantibacillus plantarum | F3-2 | 800 |
| Lactiplantibacillus plantarum | YZX21 | 500 |
| Lactiplantibacillus plantarum | H-87 | 600 |
| Lactiplantibacillus plantarum | LP-C2 | 800 |
| Lactiplantibacillus plantarum | LP-C3 | 500 |
| Lactiplantibacillus plantarum | LP-C1 | 600 |
| Lactiplantibacillus plantarum | LP-C5 | 300 |
| Lactiplantibacillus plantarum | LP-C77 | 800 |
| Lacticaseibacillus paracasei | G15 | 500 |
| Lacticaseibacillus paracasei | J5 | 800 |
| Lacticaseibacillus paracasei | X11 | 800 |
| Lacticaseibacillus paracasei | LPC-C8 | 500 |
| Lacticaseibacillus paracasei | LPC-C7 | 800 |
| Lacticaseibacillus paracasei | Lpc-C66 | 800 |
| Lacticaseibacillus paracasei | LPC-C6 | 500 |
| Lacticaseibacillus casei | YRL577 | 500 |
| Lacticaseibacillus casei | LC-C64 | 500 |
| Lactobacillus acidophilus | LA-C29 | 300 |
| Lacticaseibacillus rhamnosus | LR-GG | 300 |
| Lacticaseibacillus rhamnosus | LR-C55 | 500 |
| Lacticaseibacillus rhamnosus | LR-C19 | 300 |
| Bifidobacterium longum subsp. longum | BL-C54 | 200 |
| Bifidobacterium longum subsp. longum | BL-C62 | 200 |
| Bifidobacterium longum subsp. infantis | BI-C71 | 100 |
| Bifidobacterium breve | BB-C51 | 300 |
| Limosilactobacillus fermentum | LF-C57 | 500 |
| Streptococcus salivarius subsp.thermophilus | ST-C13 | 200 |
| Pediococcus acidilactici | PA-C81 | 800 |
| Pediococcus pentosaceus | PP-C80 | 800 |
Frequently Asked Questions (FAQ)
What are the patented applications of Bifidobacterium animalis subsp. lactis F1-7?
Bifidobacterium animalis subsp. lactis F1-7 is patented for promoting intestinal motility (Patent ZL202110565814.X). Additionally, it has a patent for its combination with krill oil to help ameliorate atherosclerotic inflammation (Patent ZL202110019976.3).
In what applications can these probiotic strains be utilized?
These probiotic strains are versatile and can be formulated for use in Dairy products, general Food, Fermented Beverages, Pharmaceuticals, Biotechnology, and Feed Additives/Pet food.
Are customized probiotic products available?
Yes, customized probiotic products are acceptable. We can tailor formulations based on your specific requirements.
What potency options do you offer for the probiotic powders?
We offer multiple potency options including 10B CFU/g, 50B CFU/g, 100B CFU/g, 200B CFU/g, 300B CFU/g, 400B CFU/g, and 500B CFU/g.
Has the efficacy of these probiotic strains been scientifically studied?
Yes, there are numerous literature studies supporting these strains, demonstrating their benefits in improving cholesterol metabolism, alleviating atherosclerosis, regulating metabolism related to type 2 diabetes, and relieving constipation.